Cereno Scientific to Attend JPM Week and Biotech Showcase in San Francisco, US, on January 12-18, 2026
GOTHENBURG, Sweden, Dec. 12, 2025 /PRNewswire/ — Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and... Read more.
GCL SI Joins COP30 Efforts to Standardize Global Carbon Credits
SUZHOU, China, Dec. 12, 2025 /PRNewswire/ — As global attention turns to carbon credit standardization and traceability, in light of the recent COP30 climate... Read more.
tree DIGITAL INSURANCE AGENCY WINS BIG AT GLOBAL BRAND AWARDS 2025
LONDON, Dec. 12, 2025 /PRNewswire/ — tree has been recognised as the Fastest Growing Digital Insurance Provider in Saudi Arabia at the renowned Global Brand... Read more.
TELUS Announces Upsizing and Results of its Cash Tender Offers for Seven Series of Debt Securities
VANCOUVER, BC, Dec. 12, 2025 /CNW/ – TELUS Corporation (“TELUS” or the “Company“) today announced (i) the release of the results of... Read more.
US Luxury and Exotic Car Market Set to Reach Up to $215 Billion by 2035–Nearly Twice Its Current Size
New BCG and duPont REGISTRY Study Explores How Luxury Car Brands Can Adapt to Fading Loyalty, Changing Digital Habits, and Shifting Ownership Expectations Secondary... Read more.
COMEUP 2025: Recode the Future –Officially Opens in Seoul from December 10-12
Korea’s largest startup festival, COMEUP 2025, opens on December 10 (KST), bringing together innovative startups, global and domestic investors, and major... Read more.
WSPN Achieves ISO/IEC 27001:2022 Certification, Reinforcing Its Commitment to World-Class Information Security
TORTOLA, British Virgin Islands, Dec. 11, 2025 /PRNewswire/ — Worldwide Stablecoin Payment Network (WSPN), a leading provider of next-generation stablecoin... Read more.
ZIEA Unveils World’s First AI Desktop Calendar Designed to Reclaim Your Focus in an Age of Distraction
SAN FRANCISCO, Dec. 11, 2025 /PRNewswire/ — ZIEA, an innovator in personal productivity hardware, today announced the upcoming launch of the ZIEA AI Calendar,... Read more.
Cadonilimab (PD-1/CTLA-4) Receives FDA Clearance for Global Phase III First-Line Gastric Cancer Trial Versus Nivolumab
HONG KONG, Dec. 11, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced FDA approval to initiate COMPASSION-37/AK104-311... Read more.
StreamKey to Represent SJE Rhombus Across Key Midwest and Appalachian Markets
Collaboration brings responsive, on‑the‑ground support to IN, KY, OH, WV, and Western PA. DETROIT LAKES, Minn., Dec. 11, 2025 /PRNewswire/ — SJE Rhombus... Read more.